Clinical Trial: Mesenchymal Stem Cell Exosomes Alone or Combined With HUVEC Exosomes in Non-Dialysis Chronic Kidney Disease

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07922889) titled 'Mesenchymal Stem Cell Exosomes Alone or Combined With HUVEC Exosomes in Non-Dialysis Chronic Kidney Disease' on Nov. 02.

Brief Summary: The goal of this clinical trial is to learn whether a single intravenous injection of exosomes derived from human Wharton's jelly mesenchymal stem cells (HWJ-MSC), given alone or together with exosomes derived from human umbilical vein endothelial cells (HUVEC), is safe and can help slow the progression of chronic kidney disease (CKD) in adults aged 18 to 65 years with stage 3-4 CKD who are not on dialysis.

The main questions it aims to answer are:

* Does exosome therapy, added to standard CKD care...